Medical consultation platform developer Ubie has received $18.4m from medicine distributor Suzuken that will be used to enhance its apps, increase headcount and expand internationally.

Pharmaceutical wholesaler Suzuken provided ¥2bn ($18.4m) in funding yesterday for Ubie, the Japan-based developer of an intelligent medical consultation service. Founded in 2017, Ubie provides artificial intelligence-powered consultation service for health facilities. Its products included AI-based symptom checker apps AI Monshin Ubie and Dr Ubie which help patients self-triage, allowing time for care professionals to…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.